ADIPOQ and endothelial dysfunction: In support, former studies highlighted the oxidative-inflammatory injury of UA through declining NO bioavailability leading to endothelial dysfunction [27], diminishing the anti-inflammatory adiponectin in adipose tissues [28], activating the proliferation of vascular smooth muscle cells and the production of angiotensin II [29] and initiating chronic inflammatory reactions [30].